Celgene, Teva, others must face US antitrust claims over Revlimid, judge rules
MLex Summary: Celgene, Teva, AbbVie and other companies failed to dismiss US claims that they conspired to illegally monopolize the market for Revlimid. District Judge Michae l E. Farbiarz denied the motion,...To view the full article, register now.
Already a subscriber? Click here to view full article